NDAQ:NRXP - Post Discussion
Post by
AviseAnalytics on Oct 19, 2021 8:05am
ALL YOU NEED TO KNOW ABOUT NRX PHARMACEUTICALS!
$NRXP
There is a lot of buzz around NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing ZYESAMI™ (AVIPTADIL®) for the treatment of respiratory failure in critical COVID-19 patients. The Company has recently submitted a revised Investigational New Drug (IND) module for ZYESAMI, which was met with much cheer by the investors. However, RELIEF THERAPEUTICS Holding AG has filed a lawsuit against the Company, claiming failure to honor its obligations under the collaboration agreement entered between the companies in September 2020. Read on to find out more! https://www.aviseanalytics.com/all-you-need-to-know-about-nrx-pharmaceuticals/
Be the first to comment on this post